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LPSPhagocytosis of pathogens, apoptotic cells and debris is a key feature of macrophage function in host
defense and tissue homeostasis. Quantification of macrophage phagocytosis in vitro has traditionally
been technically challenging. Here we report the optimization and validation of the IncuCyte ZOOM real
time imaging platform for macrophage phagocytosis based on pHrodo pathogen bioparticles, which
only fluoresce when localized in the acidic environment of the phagolysosome. Image analysis and fluo-
rescence quantification were performed with the automated IncuCyteTM Basic Software. Titration of the
bioparticle number showed that the system is more sensitive than a spectrofluorometer, as it can detect
phagocytosis when using 20 less E. coli bioparticles. We exemplified the power of this real time imaging
platform by studying phagocytosis of murine alveolar, bone marrow and peritoneal macrophages. We
further demonstrate the ability of this platform to study modulation of the phagocytic process, as phar-
macological inhibitors of phagocytosis suppressed bioparticle uptake in a concentration-dependent man-
ner, whereas opsonins augmented phagocytosis. We also investigated the effects of macrophage
polarization on E. coli phagocytosis. Bone marrow-derived macrophage (BMDM) priming with M2 stim-
uli, such as IL-4 and IL-10 resulted in higher engulfment of bioparticles in comparison with M1 polariza-
tion. Moreover, we demonstrated that tolerization of BMDMs with lipopolysaccharide (LPS) results in
impaired E. coli bioparticle phagocytosis. This novel real time assay will enable researchers to quantify
macrophage phagocytosis with a higher degree of accuracy and sensitivity and will allow investigation
of limited populations of primary phagocytes in vitro.
 2016 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Macrophages are innate immune cells that respond to inflam-
mation, tissue trauma or infection. They were first identified in
the nineteenth century by Elie Metchnikoff in sea-star larvae for
their ability to surround and engulf a rose thorn, a process he ter-
med phagocytosis [1]. Together with monocytes and dendriticcells, macrophages make up the mononuclear phagocyte network
and play an important role in tissue homeostasis [2]. Macrophages
are equipped with a range of highly conserved pattern recognition
receptors (PRRs) which bind to conserved pathogen-associated
molecular patterns (PAMPs), such as lipopolysaccharide (LPS) on
Gram-negative bacteria [3,4]. Similarly, danger-associated molecu-
lar patterns (DAMPs), such as high mobility group box 1 [5], IL-1a
[6] and uric acid [7] are released by necrotic cells during sterile
injury and trigger the activation of macrophages.
Upon PRR engagement, receptor clustering brings together tyr-
osine kinases which initiate the internalization of foreign particles
[8–11]. Downstream signaling induces the engulfment of the for-
eign object via protrusions of the cell membrane to form a
membrane-bound vesicle [12–14]. The newly formed vesicle,
called the phagosome, undergoes maturation whereby it fuses
with several compartments of the endocytic system as it is trans-
ported within the cytosol [15]. Earlier work has shown that during
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hydrolases, proton pump ATP subunits and endosome fusion pro-
teins [16]. Changes in the phagosome membrane and its content
are continuous, well-orchestrated and eventually lead to its acidi-
fication [17,18].
When phagosome maturation is complete, these organelles fuse
with lysosomes which carry an arsenal of hydrolytic enzymes and
anti-microbial peptides [19]. The acidic and highly oxidative envi-
ronment of the phagolysosome is essential for the activation of
cathepsins, oxidants and cationic peptides which eventually lead
to pathogen lysis and clearance [20].
Researchers have employed a variety of assays to study phago-
cytosis, including light and confocal microscopy, flow cytometry
and imaging flow cytometry and spectrofluorometry. However,
technical and practical limitations are associated with all of these
techniques, such as dye quenching, low throughput, single end
point readouts and often subjective quantification. ESSEN BioS-
cience developed the IncuCyte ZOOM, a platform which utilizes
microscopy to monitor phagocytosis in real time. In this study
we report the optimization and validation of this live cell imaging
platform to quantify primary murine and human macrophage
phagocytosis. We show that this platform is 20 times more sensi-
tive than spectrofluorometry and can detect signals from limited
primary macrophage populations.2. Materials and methods
2.1. Reagents
Fetal Bovine Serum (FBS), LPS (O111:B4), BSA, RPMI-1640 med-
ium, phorbol 12-myristate-13-acetate (PMA), Bafilomycin A1,
Nocodazole and Cytochalasin D were purchased from Sigma-
Aldrich (Gillingham, Dorset, UK). PBS was from Lonza (Slough,
UK). EDTA was purchased from VWR technologies (East Grinstead,
UK). OptiMEM I reduced serum medium, Live Cell Imaging Solu-
tion, Penicillin/Streptomycin, green pHrodo E. coli and red S. aur-
eus Bioparticles were from Life Technologies (Paisley, UK). Sterile
IncuCyteTM green pHrodo E. coli and Zymosan were purchased
from ESSEN Bioscience (Welwyn Garden City, UK). Cytokines
(Interferon-c (IFN-c), interleukin -4 (IL-4) and IL-10) were from
Peprotech (London, UK).2.2. Cell lines
Cell lines were originally from American Type Culture Collec-
tion. The RAW264.7 and THP-1 cell lines were a kind gift from Prof.
Siamon Gordon, the BV-2 cell line was kindly provided from Prof.
David Vaux. Macrophage cell lines at passage number 5 were cul-
tured in RPMI-1640 medium containing 10% FBS and 1% Penicillin/
Streptomycin at 37 C/5% CO2. Cells were passaged every three
days. THP-1 cells were stimulated with 50 ng/ml PMA for four days
before the phagocytosis assay.2.3. Animals
All animal experiments were conducted with local ethical
approval from the Dunn School of Pathology Local Ethical Review
Committee and in accordance with the UK Home Office regulations
(Guidance on the Operation of Animals, Scientific Procedures Act,
1986). Male 8–10 week old C57BL/6J mice (25–30 g) were pur-
chased from Harlan Laboratories (Bicester, UK). All animals were
housed in a 12 h light/dark cycle unit with free access to food
and water.2.4. Bone marrow-derived macrophages (BMDMs)
BMDMs were generated as previously described [21]. Briefly,
tibiae and femurs from male C57BL/6J mice were flushed with
PBS and bone marrow cells were re-suspended in Dulbecco Modi-
fied Eagle’s Medium supplemented with 10% heat-inactivated FBS,
10–15% L929-conditioned medium [22] and 1% Penicillin-
Streptomycin. Cells were cultured for seven days at 37 C/5% CO2
and were re-fed on day 3.
2.5. Human induced Pluripotent Stem (hiPS) cell-derived macrophages
The hiPS cell line AH017-13 was derived from dermal fibrob-
lasts of healthy donors recruited by the Oxford Parkinson’s Disease
Centre (Ethics committee: National Health Service, Health
Research Authority, NRES Committee South Central – Berkshire,
UK – REC 10/H0505/71), reprogrammed using standardized proto-
cols in the James Martin Stem Cell Facility, Sir William Dunn School
of Pathology, and their SNP datasets and transcriptome array
results are deposited in Gene Expression Omnibus (GEO) under
accession numbers GSE 53426 [23]. For this study, hiPSCs were
thawed and cultured as described in [23]. Differentiation to macro-
phages via embryoid body formation and directed differentiation
was as previously described [24].
2.6. IncuCyte ZOOM phagocytosis assay
Day 7 BMDMs in OptiMEM medium were plated into 96-well
flat clear bottom black walled polystyrene tissue-culture treated
microplates (Corning, Flintshire, UK) and allowed to adhere for
2 h. pHrodo pathogen bioparticles were added at indicated con-
centrations and the plates were transferred into the IncuCyte
ZOOM platform which was housed inside a cell incubator at
37 C/5% CO2, until the end of the assay. Two images per well from
two technical replicates were taken every 10 min for 1 h using a
20 objective lens and then analyzed using the IncuCyteTM Basic
Software. Green channel acquisition time was 400 ms, whereas
red channel acquisition time was 800 ms. In phase contrast, cell
segmentation was achieved by applying a mask in order to exclude
cells from background. An area filter was applied to exclude objects
below 50 lm2. Green and red channel background noise was sub-
tracted with the Top-Hat method of background non-uniformity
correction with a radius of 20 lm [25] and a threshold of 2 green
and red corrected units. Fluorescence signal was quantified apply-
ing a mask (Fig. 1A; 1 mg/ml bioparticles, Fig. 1B; 10 lg/ml biopar-
ticles). Moreover, as seen in Fig. 1C, in the absence of the edge split
tool the software recognizes the indicated objects as one, whereas
when edge split is applied, the objects are recognized as multiple
closely-spaced objects. Edge split was therefore used as a more
accurate quantification of fluorescent objects.
2.7. Confocal microscopy
BMDMs (2.5  104 cells per well) were seeded into IBIDI l-plate
96 well plates (Munich, Germany) in OptiMEM medium and
allowed to adhere for 2 h. Media were removed and replaced with
either 200 lg/ml pHrodo red S. aureus bioparticles and 200 lg/ml
FITC-conjugated Zymosan A or FITC-conjugated 2 lm latex beads
(Polysciences Inc, PA, USA) diluted in Live Cell Imaging Solution.
Cells were incubated for 1 h at 37 C 5% CO2, followed by extensive
washing. NucBlue Live ReadyProbes Reagent in live cell imaging
solution (ThermoFisher Scientific, MA, USA) was added to stain
nuclei. Images were acquired with a 100 objective lens using an
Olympus FV1200 confocal microscope (Olympus, PA, USA) fitted
with a temperature controlled stage set to 37 C and analyzed with
ImageJ software v1.49.
Fig. 1. Fluorescent object segmentation analysis by the IncuCyte Basic Software. BMDMs (105) from male C57BL/6J mice were incubated with 1 mg/ml (A) or 10 lg/ml (B)
green E. coli bioparticles and fluorescence emission was measured in the IncuCyte imaging platform for one hour at 37 C. Representative images showing the green channel
signal (left), the green object mask which was applied for quantification (middle) and the overlay of the two (right). (C) The edge split setting in the IncuCyte Basic Software
allows for quantification of closely-spaced objects in both fluorescence channels. Images from 100,000 BMDMs incubated with 1 mg/ml green E. coli bioparticles for one hour
at 37 C without (left) or with (right) edge split. The magenta lines delineate separate objects. Scale bar 100 lm. BMDMs (2.5  104 per well) were incubated with an equal
mix of 200 lg/ml red pHrodo S. aureus bioparticles and 200 lg/ml FITC-conjugated Zymosan A (D) or FITC-conjugated 2 lm latex beads (E) and phagocytosis was studied at
one hour using confocal microscopy. White arrows indicate FITC-conjugated Zymosan A or latex beads on the macrophage membrane, orange arrows indicate
unphagocytosed FITC-conjugated Zymosan A or latex beads and yellow arrows indicate unphagocytosed S. aureus bioparticles. NucBlue Live ReadyProbes reagent was used
for nuclei staining in (D). Images are from one representative of three independent experiments. Scale bar 20 lm.
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Macrophages (1  105 cells per well) were plated into a 96-well
plate (Corning) and incubated for 1 h with E. coli pHrodo bioparti-
cles at 37 C/5% CO2. Excess bioparticles were removed from each
well by washing three times with Live Cell Imaging Solution before
the measurements were made. Phagocytosis was measured using a
PHERAstar spectrofluorometer (BMG LABTECH, Aylesbury, UK)with an excitation wavelength of 485 nm and an emission wave-
length of 520 nm. Orbital averaging was used at a radius of 3 mm.
2.9. Human serum
Peripheral blood was taken from healthy volunteers according
to the University of Oxford local protocols and informed consent
was obtained. Blood was left to clot at room temperature for 2 h
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Serum was collected from the supernatant and used in
experiments.
2.10. Animal tissue preparation
Male C57BL/6 J mice were terminally anaesthetized with Isoflu-
rane, the trachea was exposed and the thorax was opened to
expose the lungs. A 0.8 mm wide plastic tube was inserted into
the trachea through an incision and attached to a 1 ml syringe.
Lungs were washed three times with 0.7 ml PBS/10 mM EDTA by
injection and withdrawal of solution. The peritoneum was lavaged
with 10 ml ice cold PBS/2 mM EDTA and cells were collected for
further use. Red blood cells were lysed with BD Pharm LyseTM (BD
Biosciences, Oxford, UK) as instructed by the manufacturer and
were re-suspended in 0.5 ml PBS/1% FBS for further use.
2.11. Flow cytometry
Lung and peritoneal harvested cells were blocked with 10 lg/ml
rat anti-mouse CD16/CD32 (AbD Serotec, Oxford, UK) and 1.17 mg/
ml murine immunoglobulin G (IgG) (Jackson ImmunoResearch
Laboratories, PA, USA) in Flow Cytometry buffer (PBS; 2% FBS,
25 mM HEPES, 5 mM EDTA) for 15 min on ice. Cells were stained
with anti-CD45 (30-F11; BD Pharmigen), anti-CD11c (HL3; BD
Pharmigen), anti-Siglec F (E50-2440; BD Pharmigen), anti-CD11b
(M1/70; Biolegend, London, UK) and anti-F4/80 (CI:A3-1; Bio-rad)
at 2 lg/ml in Flow Cytometry buffer for 30 min on ice protected
from light. Cells were washed and pelleted at 5000g for 10 min
before being re-suspended in Flow Cytometry buffer. Samples were
run on a Dako Cyan ADP flow cytometer (Beckman Coulter Ltd.,
High Wycombe, UK) and analyzed with FlowJo 10 software (Tree
Star Inc, Ashland, USA). For cell counting, CountBrightTM Absolute
Counting Beads (Life Technologies) were used as instructed by
manufacturer’s guidelines.
2.12. Quantitative Polymerase Chain Reaction (qPCR) (Table 1)
RNA extraction was carried out with the RNeasy kit (Qiagen,
Manchester, UK) and RNA quality was verified with a ND-100 spec-
trophotometer (Nano Drop Technologies, DE, USA). Complemen-
tary DNA (cDNA) was reverse transcribed from 400 to 600 ng
RNA using the QuantiTect Reverse Transcription kit (Qiagen)
according to the manufacturer’s instructions. Twenty to thirty
nanograms of cDNA were used as a template in qPCR experiments
using specific primers (500 nM) and 2X Sybr Select Master Mix as
the detection chemistry (Life Technologies). The thermal profile
included one phase at 95 C for 5 min, second phase of 40 cycles
at 95 C for 20 s, 60 C for 20 s and 72 C for 20 s and last phase
of 72 C for 5 min. Melt curve analysis was run after every experi-
ment. The experiments were carried out with a Step One Plus TM
platform (Applied Biosystems, MA, USA) and analyzed with the
StepOneTM software. Cycle threshold (Ct) values were determined
and relative mRNA contents were inferred from normalization of
the gene of interest expression to that of the housekeeping gene
(DCt). Relative expression results were plotted as (2DCt).
2.13. Statistical analysis
All data are reported as mean + SEM of n = 3–5 independent
experiments. Statistical analysis was carried out with GraphPad
Prism 6.0 (CA, USA) using one- or two-way ANOVA with Dunnett’s
or Sidak’s post hoc multiple comparisons tests, respectively. Non
parametrical Kruskal–Wallis comparisons were carried out with
Dunn’s post hoc multiple comparisons test, where data did not fol-low a normal distribution. Results were considered significant
when p < 0.05.3. Results
3.1. Cell density and phagocytic meal optimization
We first compared commercially available phagocytic meals to
use in our in vitro assay. We cultured BMDMs (2.5  104 cells per
well) with an equal mix of 200 lg/ml pHrodo red S. aureus biopar-
ticles and 200 lg/ml FITC-conjugated Zymosan A or FITC-
conjugated latex beads for 1 h and took images using confocal
microscopy. As shown in Fig. 1D and E, pHrodo-labeled S. aureus
bioparticles emitted red signal only when within macrophages.
Unphagocytosed pHrodo S. aureus bioparticles gave no red signal
(see yellow arrows in Fig. 1D and E). In contrast, both FITC-
conjugated Zymosan and latex beads were constitutively fluores-
cent and were observed following phagocytosis (see co-
localization with S. aureus bioparticles in Fig. 1D), but also when
bound to macrophage membranes (white arrows) and free in the
supernatant (orange arrows). For this reason, we decided to use
the pHrodo-labeled bioparticles for the remainder of this study.
We then sought to optimize the IncuCyte platform for pathogen
particle number and cell density. Adherent BMDMs (1  105 cells
per well) were seeded for 2 h and fed with serially diluted E. coli
bioparticles for 1 h. Fig. 2A shows that phagocytosis was particle
number-dependent with representative images shown in panels
B–D. In addition, bioparticle uptake by different BMDM densities
challenged with 200 lg/ml E. coli bioparticles followed a cell
number-dependent pattern (Fig. 2E). Based on these pilot experi-
ments we decided to use a density of 50,000 BMDMs per well
and concentration of 200 lg/ml E. coli bioparticles for the remain-
der of the study. A time lapse movie of 50,000 BMDMs phagocytos-
ing 200 lg/ml E. coli bioparticles is shown in Supplementary Fig. 1.
Finally, we measured the phagocytosis rate of several murine and
human macrophage lines and hiPS cell-derived macrophages
(Fig. 2F). hiPS cell-derived macrophages showed a remarkably high
uptake rate, whereas RAW264.7 cells and THP-1 exhibited similar
E. coli bioparticle uptake rates. In contrast, BV-2 microglia cells
phagocytosed fewer E. coli bioparticles.
A commonly used technique to measure phagocytosis of fluo-
rescent particles is Spectrofluorometry. Comparison of the Incu-
Cyte platform with a Spectrofluorometry-based system revealed
a higher degree of phagocytosis-sensitivity with the IncuCyte plat-
form (Fig. 2G). E. coli bioparticle engulfment measured by Spec-
trofluorometry had a detection limit of 20 lg/ml bioparticles in
comparison with the IncuCyte which could detect signal over back-
ground with as few as 1 lg/ml of particles.
Collectively, these results highlight the higher sensitivity and
accuracy of the IncuCyte over Spectrofluorometry-based and con-
focal microscopy platforms for quantifying macrophage phagocy-
tosis of pathogen bioparticles.3.2. Measurement of inhibitor and opsonin activity
Having optimized the IncuCyte phagocytosis assay, we wanted
to further validate the quantitative imaging platform with known
modulators of phagocytosis. We first pre-treated BMDMs with
the actin inhibitor Cytochalasin D or the microtubule inhibitor
Nocodazole for 1 h prior to the addition of E. coli bioparticles. Both
Cytochalasin D and Nocodazole reduced the number of phagocy-
tosed bioparticles in a concentration-dependent manner
(Fig. 3A and C). Nocodazole decreased E. coli bioparticle uptake
by 65% at 10 lM (p = 0.01), whereas Cytochalasin D was a more
potent inhibitor of phagocytosis (73% reduction at 1 lM,
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Fig. 2. BMDM phagocytosis is pathogen particle number and cell density-dependent. (A) BMDMs (105) from male C57BL/6J mice were incubated with green E. coli
bioparticles (1 mg/ml to 1 lg/ml) and fluorescence emission was measured in the IncuCyte imaging platform every 10 min for one hour at 37 C. (B)–(D) Representative
images from one experiment at one hour. (E) BMDMs (100,000–1562 cells per well) were incubated with 200 lg/ml green E. coli bioparticles for one hour at 37 C and
fluorescence emission was measured in the IncuCyte imaging platform with 10 min intervals. (F) RAW264.7, BV-2, THP-1 and hiPS cell-derived macrophages (5  104) were
incubated with 200 lg/ml green E. coli bioparticles and fluorescence emission was measured in the IncuCyte imaging platform every 10 min for one hour at 37 C. (G) Side-by-
side comparison of green E. coli bioparticle phagocytosis by 100,000 BMDMs measured with a spectrofluorometer and the IncuCyte system. Data are presented as mean ± SEM
from 3 to 4 biological replicates in technical duplicates, apart from F and G where data are from one experiment with two technical replicates and are presented as mean ± SD.
Scale bar 100 lm.
T.S. Kapellos et al. / Biochemical Pharmacology 116 (2016) 107–119 111p = 0.026) (Fig. 3B and D). In addition, pre-treatment of BMDMs for
1 h with Bafilomycin A1, an inhibitor of the phagolysosome V-
ATPase, resulted in ablation of the fluorescent signal above the
concentration of 100 nM (p = 0.007), demonstrating the key role
of phagolysosome acidification for detection of pHrodo-labeled
particles (Fig. 3E and F).
To address whether enhancement of BMDM phagocytosis could
also be quantified by the IncuCyte platform, we opsonized E. colibioparticles with diluted human serum from healthy individuals
or murine IgG and then delivered the meal to 50,000 BMDMs. Coat-
ing of the bioparticles with murine IgG and human serum signifi-
cantly enhanced E. coli bioparticle phagocytosis (Fig. 3G and H).
Murine IgG increased phagocytosis 2-fold (p = 0.03), while human
serum augmented particle ingestion by 2.4–2.6 (p < 0.0001). In
addition, the phagocytosis curves of BMDMs treated with human
serum-coated bioparticles exhibited a marked shift to the left,
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Fig. 3. Macrophage phagocytosis is inhibited by actin and microtubule inhibitors and enhanced by opsonization. (A)–(D) BMDMs (5  104) from C57BL/6J male mice were
pre-treated with the actin and microtubule inhibitors Cytochalasin D and Nocodazole at the indicated concentration for one hour and were then incubated with 200 lg/ml
green E. coli bioparticles at 37 C for another hour. (E) and (F) BMDMs (5  104) from C57BL/6J male mice were pre-treated with the vacuolar H+-ATPase inhibitor Bafilomycin
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platform and statistical analysis was carried out with one-way ANOVA with Dunnett’s multiple comparisons post hoc test. Data are presented as mean ± SEM from 3 to 5
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112 T.S. Kapellos et al. / Biochemical Pharmacology 116 (2016) 107–119which indicates an increased rate of bioparticle uptake as con-
firmed by the slope metric (Human Serum 1/10 = 0.08, Human
serum 1/5 = 0.08 and murine IgG = 0.04) (Fig. 3G). A time lapse
movie of human serum-pre-treated E. coli phagocytosis by BMDMs
is shown in Supplementary Fig. 2.
Taken together, these results demonstrate that macrophage
phagocytosis of bioparticles in real time is significantly reduced
by actin polymerization and microtubule inhibitors and is aug-
mented by opsonization of bioparticles. The results obtained with
Bafilomycin A1 further supports the view that this phagocytosis
methodology only detects uptake into the acidified phagolyso-
some. These findings suggest that, for the first time, there is aphagocytosis imaging platform that provides the opportunity to
study the kinetics of novel chemical compounds or treatments that
inhibit or enhance macrophage phagocytosis.3.3. Differential pattern of phagocytic activity among different
macrophage populations
One technical limitation of some macrophage phagocytosis
assays is that they require large cell numbers in order to yield a
detectable signal. We decided to test the ability of the IncuCyte
platform to quantify pathogen phagocytosis by different resident
T.S. Kapellos et al. / Biochemical Pharmacology 116 (2016) 107–119 113macrophage populations, specifically, alveolar and resident peri-
toneal macrophages.
We harvested lung and peritoneal cells from naïve mice and
stained them with antibodies to determine their number and
macrophage purity (Fig. 4A and B). Alveolar macrophages were
identified as CD45+CD11c+Siglec F+ cells and peritoneal macro-
phages as CD45+F4/80+CD11b+ cells. The absolute numbers of
these resident macrophage populations were generated from the
total cell counts and the flow cytometry gating strategy shown in
Fig. 4C and D. We decided to use 12,500 alveolar macrophages,
peritoneal macrophages or BMDMs per well and challenge them
with 200 lg/ml S. aureus, Zymosan and E. coli bioparticles for 4 h
with data collected every 15 min.
We hypothesized that each macrophage population would
respond differently to selected non-opsonized pathogen bioparti-
cles. Fig. 4E shows that alveolar macrophages uptake S. aureus 8
more efficiently than Zymosan and 5 more efficiently than E. coli
(p < 0.01) at 4 h, whereas BMDMs are effective in clearing both S.
aureus (8) and E. coli (10) (p < 0.001 in comparison to Zymosan).
Interestingly, resident peritoneal macrophages were not very effi-
cient at pathogen bioparticle engulfment in comparison with other
tissue-resident macrophages. Time kinetics showed that S. aureus
is taken up more rapidly than E. coli and Zymosan by alveolar
and peritoneal macrophages, whereas its uptake rate is similar to
that of E. coli in BMDMs (Fig. 4F–H).
The IncuCyte phagocytosis assay highlights key differences in
the ability of different primary macrophage populations to phago-
cytose different pathogens. More importantly, the system allows
users to monitor and accurately quantify phagocytosis by primary
macrophage populations where only small numbers of cells can be
obtained, which would not be feasible if using another phagocyto-
sis methodology.
3.4. Long term phagocytosis assays with different macrophage seeding
densities
To illustrate the IncuCyte platform’s ability to carry out long-
term imaging and explore the full dynamic range of the assay,
we seeded BMDMs at different densities (50,000–3125 cells per
well) and performed a phagocytosis assay using 200 lg/ml green
E. coli or red S. aureus bioparticles for 24 h (Fig. 5).
E. coli engulfment exhibited a biphasic response with peaks at 4
and 24 h, whereas S. aureus uptake reached a plateau at 5 h after
which the signal remained constant until 24 h (Fig. 5B). Taken
together, these data further demonstrate the advantage of kinetic
studies over single endpoint assays and exemplify the IncuCyte plat-
form’s advantage over current methodologies to study macrophage
phagocytosis in both short-term and long-term in vitro assays.
3.5. Macrophage polarization is an important determinant of
phagocytic activity
To explore how the IncuCyte system can be used to address sci-
entific questions about macrophage biology, we polarized BMDMsTable 1
Primers used for detection of M1 and M2 polarization markers.
Gene Primer Primer sequence (50 ? 30)
Mm_Nos2 Sense CAAGCCCTCACCTACTTCCTG
Antisense AATCTCTGCCTATCCGTCTC
Mm_Arg1 Sense ACCTTGGCTTGCTTCGGA
Antisense CTGTCTGCTTTGCTGTGAT
Mm_Mrc1 Sense TGTGTAGTTGTGATTGGTGG
Antisense TGGAGTAGTGGTTGGAGAAA
Mm_Actg1 Sense CCAACAGCAGACTTCCAGGATT
Antisense CTGGCAAGAAGGAGTGGTAACTGto an M1 phenotype with 100 ng/ml LPS and 20 ng/ml IFN-c or an
M2 phenotype with 20 ng/ml IL-4 and 10 ng/ml IL-10 for 16 h and
measured the mRNA expression levels of signature genes, such as
Nos2 for the M1 and Arg1 and Mrc1 for the M2 phenotype
(Fig. 6A–C).
Polarized BMDMs (5  104) were incubated with E. coli biopar-
ticles and phagocytosis was scored as before (Fig. 6D and E). Fig. 6D
shows that treatment of BMDMs with LPS or IFN-c led to signifi-
cantly lower E. coli bioparticle uptake at 1 h (p < 0.01) compared
to pre-treatment with IL-4 or IL-10. Moreover, M1 but not M2
polarization resulted in a significant reduction in phagocytosis
compared to vehicle-pre-treated macrophages (p < 0.01).
These data show that polarization of primary macrophages
using cytokines can modulate their capacity to engulf pathogens
and that the M1 phenotype significantly impairs uptake of E. coli
into acidified phagolysosomes. Therefore, questions relating to
how primary macrophage polarization affects phagocytosis can
be addressed with this system.3.6. LPS exposure tolerizes macrophages and compromises
phagocytosis
The fact that M1 polarized BMDMs displayed weaker phago-
cytic activity in comparison with M2 macrophages prompted us
to look into this observation in more detail. We therefore pre-
treated BMDMs with a range of LPS concentrations for 16 h,
washed and cultured the cells in macrophage culture media for a
further 24 h (in the absence of LPS) and finally administered E. coli
bioparticles for 1 h (Fig. 7A). We hypothesized that LPS-pre-treated
BMDMs would be tolerized and therefore respond differently to a
subsequent presentation of E. coli bioparticles compared to
vehicle-treated cells, resulting in altered kinetics of phagocytosis.
Pre-treatment of BMDMs with 100 ng/ml LPS resulted in
reduced mRNA expression levels of cytokines and chemokines,
such as Tnf, Ccl2 and Ccl3, and increased the expression of Il6,
Nos2 and Ccl5 in comparison with untreated macrophages (data
not shown). We found that LPS pre-treatment inhibited BMDM
phagocytosis in a concentration-dependent manner (Fig. 7B). Pre-
treatment with 100 ng/ml LPS resulted in 62% reduction in phago-
cytosis when compared to vehicle-treated BMDMs (p = 0.003, rep-
resentative images from one experiment are shown in Fig. 7C).
Taken together, these results imply that one possible reason why
M1 polarized macrophages are less efficient at E. coli bioparticle
engulfment is TLR stimulus-mediated tolerance.4. Discussion
In this study we describe a novel imaging platform to quantify
macrophage phagocytosis in vitro. This technology combines pH-
dependent dye particle labeling, the acquisition of images in real
time and operator-independent image analysis. We have exempli-
fied the quantitative aspect of this technology platform using drugs
that inhibit cytoskeletal changes and lysosome acidification. Fur-
thermore, we show the ability to quantify enhancement of phago-
cytosis in primary macrophages using repeated measures every
10 min. We hereby show that this technology can be successfully
applied to overcome common technical limitations when carrying
out phagocytosis assays in vitro.
Foreign object phagocytosis has traditionally been studied as
the uptake of microspheres, fluorescent pathogens or sheep ery-
throcytes. The advantage of using the commercially available
pHrodo pathogen bioparticles is that they only fluoresce when they
are localized in an acidic micro-environment, like that of the
phagolysosome. Our data clearly demonstrate that pHrodo-
labeled bioparticles do not fluoresce when bound to the macro-
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Fig. 4. Primary murine macrophage populations exhibit differential efficiency of phagocytosis of different pathogens. C57BL/6J murine lungs and peritoneal cavities were
lavaged and cells were lysed to remove red blood cells. (A) Alveolar macrophages were defined as Siglec F+ and CD11c+ cells within the CD45+ cell population of total lung
cells. (B) Peritoneal resident macrophages were defined as F4/80+ and CD11b+ cells within the CD45+ cell population of total peritoneal cavity cells. (C) and (D) Macrophage
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sterile Zymosan, E. coli and red S. aureus bioparticles for four hours and fluorescence emission was measured in the IncuCyte imaging platform every 15 min. (F)–(H) Kinetics
of pathogen phagocytosis; 12,500 alveolar (F), peritoneal (G) and murine BMDMs (H) over four hours measured in the IncuCyte platform every 15 min. Data at four hours are
presented as mean ± SEM from 4 biological replicates in technical duplicates. Statistical analysis was carried out with a two-way ANOVA and Tukey’s post hoc multiple
comparisons test.
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trast to latex beads or FITC-labeled pathogens. Microscopy [26,27]
and flow cytometry techniques [28] have been used to visualize
and quantify phagocytosis of E. coli bioparticles by non-adherent
phagocytic cells or macrophage cell lines. However, primary
macrophages can be stressed when detached from plastic to be
run on a flow or imaging flow cytometer and quantification of
phagocytosis from microscopy image analysis is of low throughput
and potentially open to operator bias. The platform we presenthere uses microscopy to capture and quantify primary murine
macrophage phagocytosis and has no negative impact on cell
viability.
An innovative technical feature of the IncuCyte is the data anal-
ysis software. The operator is required to set up definition pro-
cesses which are then applied universally to all images of
interest eliminating the potential for bias. Data acquisition strin-
gency can be increased via modifications in the cell size and fluo-
rescence intensity threshold and closely localized objects can
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12,500 and 3125 cells per well and incubated with 200 lg/ml green E. coli (A) or red
S. aureus (B) bioparticles. Fluorescence signal was measured in the IncuCyte
imaging platform every 20 min for 24 h at 37 C. Data are presented as mean ± SEM
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C57BL/6J male mice were subsequently incubated with 200 lg/ml green E. coli biopart
platform for one hour every 10 min. (E) Time kinetics of the macrophage polarization exp
duplicates. Statistical analysis was carried out with one-way ANOVA with Dunnett’s muTo investigate the sensitivity of the IncuCyte platform, we
titrated the particle numbers in the phagocytic meal given to pri-
mary murine macrophages. Initial experiments showed that the
IncuCyte could reliably detect fluorescent signal from 20 fewer
pathogen particles than the spectrofluorometer. To further illus-
trate the power of this novel platform to effectively quantify parti-
cle fluorescence from limited primary macrophage sources, we
isolated murine alveolar and peritoneal macrophages and com-
pared them side by side with BMDMs (12,500 cells per well).
Foreign particle engagement with scavenger, Fcc or comple-
ment receptors on the macrophage plasma membrane leads to
the activation of small GTPases of the Rho family and the induction
of actin filament re-arrangement and microtubule formation [29–
33]. Pharmacological inhibition with the actin re-arrangement
inhibitor Cytochalasin D and the microtubule inhibitor Nocodazole
highlighted the importance of these signaling pathways in phago-
some formation and transport within the macrophage, as both
drugs abrogated E. coli uptake by macrophages. The observed dif-
ferences in the efficiency of the two drugs suggest that the Incu-
Cyte platform might prove a valuable tool in deciphering the
contribution of individual proteins or regulatory complexes in
the phagocytic process. In addition, pre-treatment of macrophages
with the inhibitor of the phagolysosome V-ATPase Bafilomycin A1,
ablated signal detection. The V-ATPase is a protein complex located
on the phagolysosome membrane and is the major mechanism
responsible for the inhibition of phagolysosome passive H+ leak
into the cytosol [34]. Our data confirm that the signal quantified
by our assay is pH sensitive and therefore corresponds to the late
phagosome stage of E. coli phagocytosis when bioparticles have
been completely engulfed by the macrophages.
Phagocytes are equipped with FccRs and express receptors for
C1 peptide and C3 fragments, such as C3b and iC3b that mediate
the opsonization of coated cells, microbes or surfaces [35–38].
Moreover, immunoglobulins have been shown to increase the earlyTime (minutes)
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and opsonization accelerates the clearance of microbes, such as
fungi [40,41], viruses [42] and parasites [43]. Our experiments
demonstrate that opsonization of the phagocytic meal with human
serum or murine IgG increases the ability of macrophages to clear
E. coli. Although it was originally shown that there are differences
in the mechanisms and downstream signaling between the two
processes [44–46], the fact that complement receptors have been
reported to act independently of complement and in an
antibody-mediated manner raises the possibility that it may act
in synergy with immunoglobulins to clear serum-coated E. coli par-
ticles more potently than murine IgG-coated particles [47–49].
Furthermore, serum contains a plethora of other opsonins, such
as collectins, fibronectin and pentraxins [50], which can have an
additive effect on complement’s functions and may explain the sig-
nificantly higher serum coated E. coli uptake by BMDMs compared
to murine IgG in our assays.It has been shown that the functions of different tissue-resident
macrophages are largely shaped by their micro-environment
[51,52] and macrophages are integrated with their niche to per-
form tissue-specific functions in homeostasis [53]. We therefore
hypothesized that macrophage populations from different anatom-
ical sites would exhibit differences in phagocytic activity for differ-
ent pathogens. To the best of our knowledge, we are the first to
directly compare phagocytosis between different primary macro-
phage populations and show significant variation in macrophage
pathogen preference over a range of phagocytic meals. Alveolar
macrophages displayed preference for S. aureus, in contrast to
BMDMs which cleared E. coli and S. aureus with equal efficiency.
One explanation could be the differential expression of scav-
enger receptors, C-type lectins and integrins between macrophage
populations, such as alveolar, peritoneal and microglia cells [54].
This differential pathogen uptake by macrophages is also illus-
trated in our long-term assays, where the same macrophage popu-
Table 2
Comparison of the IncuCyte ZOOM platform with other commonly used techniques for phagocytosis quantification.
IncuCyte ZOOM Spectrofluorometry Confocal microscopy Flow cytometry Imaging flow cytometry
Sensitivity +++ ++ +++ ++ ++
Magnification ++ N/A +++ N/A +++
Cell viability +++ +++ +++ + +
Real time kinetics +++ +++ N/A N/A N/A
Low cell numbers +++ + +++ ++ +++
Potential for operator bias + + +++ + +
T.S. Kapellos et al. / Biochemical Pharmacology 116 (2016) 107–119 117lation engulfed E. coli bioparticles with different kinetics from S.
aureus biparticles. These data highlight the ability of the IncuCyte
platform to carry out long-term in vitro assays and will facilitate
the study of macrophage responses to infection with different
pathogens.
Macrophages are primed by a wide range of PAMPs and DAMPs
and acquire different phenotypes according to the stimulus that
activated them [55]. M1 macrophages secrete pro-inflammatory
cytokines and chemokines, while M2 macrophages specialize in
wound healing and resolution of inflammation [56,57]. The poten-
tial of the IncuCyte to be used as a tool in macrophage biology
studies is exemplified by our finding that M2 macrophages dis-
played a significantly higher phagocytic capacity than M1 macro-
phages. Our results agree with Li et al. who showed that M2
macrophages exhibited a higher uptake of H. ducreyi and E. coli
than M1 macrophages [58]. It was recently reported that macro-
phage colony stimulating factor-differentiated macrophages are
more efficient at phagocytosis of rituximab-opsonized B-CLL tumor
cells than granulocyte-macrophage colony stimulating factor-
differentiated macrophages [59]. In contrast to Varin et al., we
did not observe an IL-4-driven inhibition of pathogen phagocytosis
which might be related to the different bacterial pathogens used in
the two studies [60].
Excessive toll-like receptor (TLR) activation of macrophages can
lead to infection, chronic inflammation and autoimmunity. Several
mechanisms of TLR activation regulation have been described so
far, including signaling and transmembrane inhibitors, soluble
decoy TLRs and reduction in the expression of TLR genes [61].
Another mechanism by which macrophage activation is restrained
is tolerance induction. Specifically, endotoxin tolerance is defined
as a hyporesponsive state induced in immune cells when repeat-
edly challenged with low doses of endotoxin [62]. Endotoxin toler-
ant macrophages bear some similarities with the M2 phenotype
and decrease the expression of pro-inflammatory cytokines and
chemokines [63]. In contrast, they promote secretion of anti-
inflammatory cytokines and expression of scavenger receptors
[62,63]. Furthermore, genes that encode tissue damage products
are epigenetically silenced, while others expressing anti-
microbial effectors are induced in tolerant macrophages [64].
Here we studied the effect of endotoxin tolerance on E. coli
phagocytosis after pre-treatment of macrophages with purified
LPS as a possible explanation for the decreased phagocytic capacity
in M1 macrophages. Our observation that E. coli phagocytosis was
inhibited in a concentration-dependent manner suggests that tol-
erance to M1 stimuli might be an important cause of impaired
phagocytic capacity of macrophage populations in vivo. Despite
this, our data are in seeming disagreement with a previous report,
where human LPS tolerant monocytes displayed enhanced phago-
cytosis of E. coli bacteria [65]. Similarly, Pena et al. showed that
peripheral blood mononuclear cells tolerized with LPS overex-
pressed macrophage receptor with collagenous structure (MARCO)
and CD23 [66]. The observed discrepancy between our current
report and others might be caused by interspecies differences.
Future work is therefore needed to understand why endotoxin tol-
erance leads to suppressed phagocytosis of E. coli particles by mur-ine BMDMs. The availability of a quantitative macrophage
phagocytosis assay will allow the molecular basis of LPS tolerance
effects to be explored in more detail.
Like all phagocytosis assays the IncuCyte-pHrodo platform
comes with some limitations. It is limited by the nature and range
of commercially available and phagolysosome-restricted phago-
cytic meals. The use of killed pathogens does not reflect the situa-
tion in vivowhere highly dividing and virulent strains of pathogens
interact with and evade the host’s immune system. In addition, the
platform detects fluorescence in one green and one red channel
each with a narrow emission spectrum that restricts the user from
additional labeling of cell compartments (Table 2).
In conclusion, we consider that the IncuCyte real time imaging
platform represents an important improvement that can be used as
a complement to current methods to study macrophage phagocy-
tosis in vitro. Its main advantage is real time acquisition of kinetic
data in short and long-term assays that allows quantitative data
analysis via its user-friendly software package. Because of its high
sensitivity, this system outperforms many current techniques used
to quantify phagocytosis and allows the study of primary murine
macrophage populations where cell numbers are a limiting factor.
This novel platform will allow us to address complex biological
questions relating to human and murine macrophage phagocytosis
and to screen for positive and negative modulators of this funda-
mental cellular process.Conflict of interest
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